{
    "clinical_study": {
        "@rank": "163022", 
        "arm_group": [
            {
                "arm_group_label": "group 2", 
                "arm_group_type": "Active Comparator", 
                "description": "Emervel\u00ae Volume Lidocaine alone in the dorsa of one hand and Emervel\u00ae Deep Lidocaine alone in the dorsa of the contralateral hand."
            }, 
            {
                "arm_group_label": "group 1", 
                "arm_group_type": "Experimental", 
                "description": "Emervel\u00ae Volume Lidocaine plus Emervel\u00ae Touch in the dorsa of one hand and Emervel\u00ae Deep Lidocaine plus Emervel\u00ae Touch in the dorsa of the contralateral hand"
            }
        ], 
        "brief_summary": {
            "textblock": "Assessment of efficacy of hyaluronic acid - Emervel\u00ae Volume Lidocaine combined or not with\n      Emervel\u00ae Touch and Emervel\u00ae Deep Lidocaine combined or not with Emervel\u00ae Touch in female\n      patients with loss of fatty tissue in hands."
        }, 
        "brief_title": "Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hands Rejuvenation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects agreeing to take part of all procedures of the study (including pre-test,\n             filler injection, photographs, etc.), after being fully informed on the objectives\n             and nature of the investigations;\n\n          -  Written Informed Consent;\n\n          -  Treatment-naive patients for fillers in hands;\n\n          -  Subjects of both genders over 18 years;\n\n          -  Fitzpatrick skin phototypes I to VI;\n\n          -  Subjects presenting a similar loss of fatty tissue on both hands, at least of 2\n             according the Validated Hand Grading Scale2;\n\n          -  Medical history and physical examination which, based on the investigator's opinion,\n             do not prevent the patient from taking part in the study and use the product under\n             investigation;\n\n          -  Female subjects of childbearing age should present a negative urine pregnancy test\n             and should be using an effective contraceptive method;\n\n          -  Availability of the subject throughout the duration of the study (208 days);\n\n          -  Subjects with sufficient schooling and awareness to enable them to cooperate to the\n             degree required by this protocol.\n\n        Exclusion Criteria:\n\n          -  Pregnant women or women intending to become pregnant in the next 18 months;\n\n          -  Subjects with known hypersensitivity to any hyaluronic acid products;\n\n          -  Subjects with history of adverse effects, such as sensitivity to the components of\n             the formula, or any other adverse effect, which in the investigator's opinion should\n             prevent the patient from participating in the study;\n\n          -  Subjects participating in other clinical trials;\n\n          -  Any prior surgery or side effects at the hands area, or any prior cosmetic\n             procedures, including permanent fillers, that may interfere with the results;\n\n          -  Subjects with active inflammation or infection in the area to be treated;\n\n          -  Subjects with a history of medical treatment non-adherence or showing unwillingness\n             to adhere to the study protocol;\n\n          -  Subjects presenting diseases such as coagulation disorders or under the use of\n             anticoagulants, or any condition that, in the opinion of the investigator, can\n             compromise the evaluation of the study."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774396", 
            "org_study_id": "08-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "group 1", 
                "description": "Emervel\u00ae Touch will be injected only in the intervention group.", 
                "intervention_name": "Emervel\u00ae Touch", 
                "intervention_type": "Drug", 
                "other_name": "Emervel\u00ae Touch"
            }, 
            {
                "arm_group_label": [
                    "group 2", 
                    "group 1"
                ], 
                "description": "Emervel\u00ae Volume Lidocaine and Emervel\u00ae Deep Lidocaine will be injected in the group #2.", 
                "intervention_name": "Emervel\u00ae Volume Lidocaine and Emervel\u00ae Deep Lidocaine", 
                "intervention_type": "Drug", 
                "other_name": "Emervel\u00ae Volume Lidocaine and Emervel\u00ae Deep Lidocaine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Hyaluronic Acid", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Hands Rejuvenation, fillers", 
        "lastchanged_date": "August 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "RS", 
                    "zip": "90570-040"
                }, 
                "name": "Brazilian center of Dermatology Studies"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Trial On The Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid (Emervel\u00ae Volume Lidocaine, Emervel\u00ae Deep Lidocaine And Emervel\u00ae Touch) In Hands Rejuvenation", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assessment of efficacy of hyaluronic acid - Emervel\u00ae Volume Lidocaine combined or not with Emervel\u00ae Touch (Galderma) and Emervel\u00ae Deep Lidocaine combined or not with Emervel\u00ae Touch (Galderma) in female patients with loss of fatty tissue as a sign of aging on hands by Global Aesthetic Improvement scale1 and Hand Grading Scale2.", 
            "measure": "Efficacy of hyaluronic acid - Emervel\u00ae Volume Lidocaine combined or not with Emervel\u00ae Touchand Emervel\u00ae Deep Lidocaine combined or not with Emervel\u00ae Touch in subjects with with loss of fatty tissue", 
            "safety_issue": "No", 
            "time_frame": "at baseline and up to 180 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774396"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brazilan Center for Studies in Dermatology", 
            "investigator_full_name": "Doris Hexsel", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brazilan Center for Studies in Dermatology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brazilan Center for Studies in Dermatology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}